A Guide To Cervical Cancer Clinical Trials
This actionable cervical cancer lays out the considerations when managing your diagnosis to help you with the process and to make sure no step is missed along the way.
Cervical cancer occurs when cancer develops in the cervix, which connects the vagina and the uterus. Cervical cancer is the second most common cancer type for women with 12.8% of women being diagnosed throughout their life.
Over 268,000 new cases last year alone. 67% of cervical cancer patients have the subtype HR+/HER2, which makes it the most common by far considering the next most common subtype being HR-/HER2, which includes about 10% of the patient population.
The two subtypes of cervical cancer are squamous cell carcinoma and adenocarcinoma.
Trials Can Help
There are approximately 400 clinical trials across the US for cervical cancer. These trials are investigating new treatments and detection methods that could save lives in the future such as:
- Targeted biomarker-based therapy
- Immunotherapy for recurrent/relapsed cancers
- Combination radiation with low dose chemotherapy
Participating in a clinical trial not only progresses much-needed research but gives patients access to these new innovative therapies years before the general population.
At Massive Bio, our mission is to enable cancer patients to have equal access to cutting-edge therapies and clinical trials, regardless of their location and/or financial stability.
Our Artificial Intelligence (AI) powered Clinical Trial Matching System connects patients and their treating oncologists to clinical trials according to their unique cancer case.
We enlist dedicated staff to collect medical records and treatment history and match patients to eligible trials near their home. We provide full support throughout your enrollment process to ensure logistics are handled so you can concentrate on your health.